Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/02/2003WO2003080570A2 Recombinant expression vectors for functional nav1.9 sodium channels
10/02/2003WO2003080569A2 Egfr ligands and methods of use
10/02/2003WO2003080141A1 Biomatrix and method for producing the same
10/02/2003WO2003080122A1 Method and agent for producing therapeutically active blood compositions
10/02/2003WO2003080113A1 Mucosal immune vaccine for periodontal diseases
10/02/2003WO2003080112A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003WO2003080106A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080083A1 Use of adenoviruses mutated in the va genes for cancer treatment
10/02/2003WO2003079995A2 Neisseria mutants, lipooligosaccharides and immunogenic compositions
10/02/2003WO2003079987A2 A non-selective cation channel in neural cells and methods for treating brain swelling
10/02/2003WO2003079977A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003WO2003079968A2 Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
10/02/2003WO2003079966A2 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging
10/02/2003WO2003079805A1 Cross-linked gelatin
10/02/2003WO2003079776A2 Identification of the flt1 gene required for angiogenesis in zebrafish, and uses thereof
10/02/2003WO2003079769A1 Functional plant, promoter to be used for producing the functional plant and method of using the same
10/02/2003WO2003079748A2 Potentiation of cancer therapies by znf217 inhibition
10/02/2003WO2003060121A9 Compositions and methods relating to gastric specific genes and proteins
10/02/2003WO2003051910A3 Inhibitors of hepatitis c virus protease
10/02/2003WO2003050139A3 Prion inhibiting peptides and derivatives thereof
10/02/2003WO2003048299A3 Novel spore wall proteins and genes from microsporidia
10/02/2003WO2003046180A3 Human cdnas and proteins and uses thereof
10/02/2003WO2003043669A8 Composition and method for treatment of wounds
10/02/2003WO2003033661A3 Methods of using 279, a human g protein-coupled receptor
10/02/2003WO2003033534A3 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof
10/02/2003WO2003027274A3 Purified polypeptides from pseudomonas aeruginosa
10/02/2003WO2003024991A3 Tall-1 receptor molecules and uses thereof
10/02/2003WO2003018037A3 Regulation method of cell growth
10/02/2003WO2003015692A3 Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same
10/02/2003WO2003015505A3 An animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy
10/02/2003WO2003014314A3 13 human secreted proteins
10/02/2003WO2003011906A3 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
10/02/2003WO2003010199A3 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
10/02/2003WO2003010194A3 Meningococcus adhesins nada, app and orf 40
10/02/2003WO2003006665A8 Lawsonia intracellularis
10/02/2003WO2003006604A3 Cyclic peptides as potent and selective melanocortin-4 receptor agonists
10/02/2003WO2003006493A3 Histidine phosphatase interacting protein with 180kd
10/02/2003WO2003004655A3 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences
10/02/2003WO2003000893A3 Nucleic acids encoding g protein-coupled receptors
10/02/2003WO2002096935A3 Long lasting fusion peptide inhibitors for hiv infection
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002090382A3 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
10/02/2003WO2002081691A9 Abcg5 and abcg8: compositions and methods of use
10/02/2003WO2002080852A3 Genes expressed in intestinal epithelium and peyer's patch m cells
10/02/2003WO2002079473A3 Molecules for diagnostics and therapeutics
10/02/2003WO2002079239A3 Chimeric filovirus glycoprotein
10/02/2003WO2002076204A3 Use of insect cell membrane transporters as novel target sites for insecticides
10/02/2003WO2002064794A3 Herbicide target genes and methods
10/02/2003WO2002061037A3 Administration of nucleic acid sequence to female animal
10/02/2003WO2002057419A3 Protein-protein interactions
10/02/2003WO2002045201A3 Non-cytolytic soluble factor from activated-expanded cd4 cells
10/02/2003WO2002044197A3 Cytokine receptor binding peptides
10/02/2003WO2002041763A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/02/2003WO2002036614A3 Peptides for use in the treatment of alzheimer's disease
10/02/2003WO2002033104A3 Antibiotic-based gene regulation system
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022875A3 Polymorphisms associated with cardiac arrythmia
10/02/2003WO2002022809A3 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
10/02/2003WO2002020570A3 Mitochondrial membrane permeabilization bv hiv-1 vpr and methods of screening
10/02/2003WO2002008383A3 Sp110, a polypeptide component of the nuclear body
10/02/2003WO2002006315A3 Novel nucleic acid and amino acid sequences
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
10/02/2003WO2002000864A3 Histone acetyltransferase inhibitors and their use as insecticides
10/02/2003WO2001098508A3 Transgenic mice containing targeted gene disruptions
10/02/2003WO2001098491A3 Osteolevin gene polymorphisms
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003WO2001086307A3 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/02/2003US20030188343 Identification of genes associated with growth in plants
10/02/2003US20030188342 Gene related to regeneration ability of plants and uses thereof
10/02/2003US20030188339 Regulatory sequences for regulation of gene expression in plants and other organisms, and compositions, products and methods related thereto
10/02/2003US20030188338 Raspberry bushy dwarf virus (RBDV) protein/polypeptide for use in generating disease resistant plants
10/02/2003US20030188336 Trangenic plant coding insecticidal protein for use in biological pest control; disease resistant plants
10/02/2003US20030188335 Chimeric & endotoxin protein with extraordinarily high insecticidal activity
10/02/2003US20030188332 Amino acid transporters
10/02/2003US20030188331 Using zinc finger polypeptide to control gene expression in transgenic plants
10/02/2003US20030188330 Transgenic plant comprising recombinant polynucleotide sequences for propagating plants which are freeze, heat, drought, insect and disease resistant
10/02/2003US20030188327 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/02/2003US20030188326 Detecting cell proliferative disorders associated with breast, ovaries or prostate via monitoring mutation in gene associated with franconi anemia; antitumor/antiproliferative agents
10/02/2003US20030188324 P300 transgenic animal
10/02/2003US20030187270 Therapy for nicotine dependency
10/02/2003US20030187246 Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof
10/02/2003US20030187244 Comprises membrane protein for use in the treatment of nervous system, cell proliferative, respiratory, hematopoietic, eating and obesity disorders
10/02/2003US20030187242 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187241 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187239 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187238 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187232 Growth factor modified protein matrices for tissue engineering
10/02/2003US20030187231 Humanized anti-TNF antibodies and peptides
10/02/2003US20030187230 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187229 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187228 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187226 Process of high purity albumin production
10/02/2003US20030187225 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003US20030187224 Chimeric OPG polypeptides
10/02/2003US20030187223 Secreted frizzled related protein,sFRP, fragments and methods of use thereof
10/02/2003US20030187222 Novel galanin receptor
10/02/2003US20030187221 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
10/02/2003US20030187219 Regulation of human alpha 1A adrenergic receptor-line G protein-coupled receptor
10/02/2003US20030187218 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
1 ... 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 ... 2916